Antinuclear Antibody (ANA) Testing Market to Soar at 12.4% CAGR to 2021
Sep 22, 2016
The worldwide antinuclear antibody (ANA) testing market (12.4% CAGR) is dominated by North America driven by the rising geriatric population while the global market is expected to reach USD 1,476.1 million by 2021 from USD 823.5 million in 2016.
Pune , India - September 22, 2016 /MarketersMedia/ —
The global antinuclear antibody (ANA) testing market is segmented based on products, diseases, techniques, end users, and regions. The assay kits& reagents segment is expected to register the highest growth rate in the antinuclear antibody (ANA) testing market, by product, during the forecast period. The high growth in this segment is attributed to the growing number of reagent rental agreements and increasing prevalence of autoimmune diseases worldwide.
Complete report on antinuclear antibody (ANA) testing market spread across 166 pages, profiling 10 companies and supported with 73 tables and 102 figures is now available at http://www.rnrmarketresearch.com/antinuclear-antibody-test-market-by-product-reagents-assay-kits-systems-software-services-technique-immunofluorescence-elisa-multiplex-disease-rheumatoid-arthritis-sle-end-user-clinical-labs-hospi-st-to-2021-market-report.html .
Based on end users, the antinuclear antibody (ANA) testing market is segmented into clinical laboratories, hospitals, POLs, and other end users. The hospitals segment is expected to account for the largest share of the market in 2016. Increasing prevalence of autoimmune diseases, coupled with the fact that most diagnostic tests are performed in hospitals or hospital-attached laboratories, will be the major factors driving the growth of this market.
North America is the largest regional segment in the global antinuclear antibody (ANA) testing market, followed by Europe, Asia, and the Rest of the World (RoW). Growth in the North American market is primarily driven by the rising geriatric population and the growing number of people covered under medical insurance in the U.S.
In addition to comprehensive geographic and product analysis and market sizing, the report also provides a competitive landscape that covers the growth strategies adopted by industry players over the last three years. The company profiles in this report comprise the product portfolios, developments, and strategies adopted by players to maintain and increase their shares in antinuclear antibody (ANA) testing market. The above mentioned market research data, current market size, and forecast of future trends will help key market players and new entrants to make the necessary decisions regarding product offerings, geographic focus, change in strategic approach and levels of output in order to remain successful in the antinuclear antibody (ANA) testing market.
The major players in antinuclear antibody (ANA) testing market include Alere Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), ERBA Diagnostics, Inc. (U.S.), Trinity Biotech plc (Ireland), Thermo Fisher Scientific, Inc. (U.S.), Antibodies, Inc. (U.S.), EUROIMMUN AG (Germany), Immuno Concepts (U.S.), Inova Diagnostics (U.S.), and Zeus Scientific, Inc. (U.S.). Get a sample copy of this research at http://www.rnrmarketresearch.com/contacts/request-sample?rname=696521 .
Objectives of the Study:
> To define, describe, and forecast the global antinuclear antibody testing market on the basis of product, technique, disease, and end user
> To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and trends)
> To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
> To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia, and the Rest of the World (RoW)
> To strategically analyze the market structure and profile the key players operating in the global ANA testing market and comprehensively analyze their core competencies
> To track and analyze competitive developments such as new product launches, agreements, expansions, and acquisitions in the global antinuclear antibody (ANA) testing market
On a related note, another research on North American Nuclear Medicine/Radiopharmaceuticals Market by Type, Therapeutic and by Application say, the market is poised to reach USD 2.98 billion by 2020 from USD 1.97 billion in 2015, growing at a CAGR of 8.6% during the forecast period of 2015 to 2020. The diagnostic radioisotopes segment is expected to account for the largest share of the North American nuclear medicine market in 2015. The SPECT applications segment is expected to account for the largest share of the North American nuclear medicine market in 2015. Increasing preference for SPECT and PET scans, alpha radio immunotherapy-based targeted cancer treatment, advances in radiotracers, growing incidence of cancer and CVDs, and rising awareness about the effective use of radiopharmaceuticals can be the major growth factors. Companies like Cardinal Health Inc., Mallinckrodt plc, GE Healthcare, Lantheus Medical Imaging, Inc., Bayer Healthcare, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Nordion, Inc., Advanced Accelerator Applications S.A. and IBA Molecular Imaging have been profiled in this 180 pages research report available at http://www.rnrmarketresearch.com/north-american-nuclear-medicineradiopharmaceuticals-stable-isotopes-market-spectpet-radioisotopes-technetium-f-18-betaalpha-radiation-therapy-i131-y-90-applications-canceroncology-market-report.html .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
For more information, please visit http://www.rnrmarketresearch.com
Contact Info:
Name: Ritesh Tiwari
Organization: RnR Market Research
Address: 2nd Floor, Metropole, Next to Inox Theatre, Bund Garden Road, Pune - 411001 Maharashtra, India.
Phone: +1-888-391-5441
Release ID: 133952
More News
Catherine Zeta-Jones hasn't read Michael Douglas' memoir yet
Catherine Zeta-Jones hasn't read Michael Douglas' memoir yet but she isn't worried about the content.
Bre Tiese reveals dealbreaker with Nick Cannon
Bre Tiesi sees Nick Cannon as her "life partner" - but she's "done" if he has any more children to add to his huge brood.
Matthew Lillard lost his house after career 'nosedived'
Scream star Matthew Lillard has revealed he lost his house and his wife went back to work becoming the main breadwinner after he suffered a major career slump.
Monica Keena found killing Freddy Krueger 'cathartic' after childhood trauma
Monica Keena found it "cathartic" killing Freddy Krueger in Freddy vs. Jason because she'd been so "traumatised" by the villain as a child.
Paul Walter Hauser to star in true crime drama Garden City
Paul Walter Hauser will star in crime drama Garden City, which is based on a true story.
Sheryl Crow says she’s 'losing a ton of money' with her latest album as she reflects on fame, cancer and ageing out of radio
Sheryl Crow says her latest record is costing her a fortune and admits she long struggled with the pressure to compete with younger pop stars dominating radio.
Ed Sheeran tour gets new opening acts after Macklemore
Two new opening acts have signed on to Ed Sheeran's tour, weeks after Macklemore's removal over his Gaza comments sparked a mass exit of performers.
Idina Menzel 'saved' by work amid Taye Diggs split
Idina Menzel's work on Frozen and If/Then "saved" her amid her split from Taye Diggs.
Jason Isaacs: 'No question' addiction would have killed me
Jason Isaacs has admitted there is "no question" his drug addiction would have killed him if he hadn't got sober 28 years ago.
Heartbreaking video emerges of Dolly Parton shortly before her death
Country superstar Dolly Parton sent a message to teachers across the world in a video which was recorded shortly before her death in August.
Travis Barker shares 'crazy' text message which changed Kourtney Kardashian relationship
Travis Barker has finally explained how his relationship with Kourtney Kardashian turned romantic - revealing she sent him a "crazy" text message making her feelings clear and it "scared" him.
Hugh Jackman explains why he signed up for Treasure Island
Hugh Jackman has explained why he signed up for Sir Ridley Scott's new adaptation of Robert Louis Stevenson's beloved pirate story Treasure Island - insisting the script was "undeniable" and "amazing".
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.